Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
17-Jun-25 | Buy | Heather Preston | 324.00p | 11,389 | £36,900.36 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
17-Jun-25 | Buy | Heather Preston | 324.00p | 11,389 | £36,900.36 |
Notifier | Holding | Value* |
---|---|---|
Roch Doliveux | 309,808 | £1,443,705 |
Heather Preston | 29,687 | £138,341 |
Frank Mathias | 20,000 | £93,200 |
Namrata P Patel | 9,170 | £42,732 |
Dame Kay Davies | 1,000 | £4,660 |
Notifier** | Holding | Value* |
---|---|---|
Briarwood Chase Management LLC | 13,851,927 | £64,549,980 |
Novo Nordisk Foundation | 12,048,802 | £56,147,417 |
Institut Merieux SA | 11,510,481 | £53,638,842 |
Briarwood Chase Management LLC | 11,171,966 | £52,061,362 |
VULPES LIFE SCIENCES FUND | 8,447,390 | £39,364,837 |
Liontrust Asset Management | 6,078,799 | £28,327,203 |
M&G Plc | 5,872,847 | £27,367,467 |
Legal & General Group Plc | 5,760,126 | £26,842,187 |
HSBC Global Custody Nominee (UK) Ltd | 4,700,000 | £21,902,000 |
Ameriprise Financial, Inc. | 4,108,146 | £19,143,960 |
Columbia Threadneedle Investments (London) | 3,834,977 | £17,870,993 |
Canaccord Genuity Group Inc | 3,699,438 | £17,239,381 |
Hargreaves Lansdown Asset Management | 3,475,237 | £16,194,604 |
SERUM LIFE SCIENCES LTD | 3,382,950 | £15,764,547 |
Nine Ten Capital | 3,117,228 | £14,526,282 |
Lansdowne Partners (London) | 3,085,765 | £14,379,665 |
Mr. S Shah | 2,898,750 | £13,508,175 |
Artisan Partners | 2,620,800 | £12,212,928 |
Cubana Investments Limited | 2,506,000 | £11,677,960 |
Interactive Investor Sharedealing | 2,372,412 | £11,055,440 |
TDWaterhouse | 852,076 | £3,970,674 |
Self Trade Stockbrokers | 657,039 | £3,061,802 |
Currency | UK Pounds |
Share Price | 466.00p |
Change Today | 3.50p |
% Change | 0.76 % |
52 Week High | 470.00p |
52 Week Low | 232.50p |
Volume | 26,717 |
Shares Issued | 106.20m |
Market Cap | £494.89m |
Beta | 0.02 |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
No dividends found |
Time | Volume / Share Price |
10:38 | 5 @ 468.50p |
10:32 | 163 @ 466.00p |
10:32 | 163 @ 466.00p |
10:29 | 100 @ 463.91p |
10:25 | 100 @ 464.50p |
Chair | Roch Doliveux |
CEO | Frank Mathias |
CFO | Lucinda (Lucy) Crabtree |
You are here: research